Literature DB >> 2529891

Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma.

M N Norazmi1, A W Hohmann, J M Skinner, J Bradley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2529891      PMCID： PMC2247320          DOI： 10.1038/bjc.1989.340

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  22 in total

1.  The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion.

Authors:  C Pitzalis; G Kingsley; D Haskard; G Panayi
Journal:  Eur J Immunol       Date:  1988-09       Impact factor: 5.532

2.  Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Authors:  H M Serra; J F Krowka; J A Ledbetter; L M Pilarski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

3.  The bimolecular structure of the interleukin 2 receptor.

Authors:  K A Smith
Journal:  Immunol Today       Date:  1988-02

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells.

Authors:  L A Greenbaum; J B Horowitz; A Woods; T Pasqualini; E P Reich; K Bottomly
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

6.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Monoclonal antibodies to a human T-cell antigen and Ia-like antigen in the characterization of lymphoid leukemia.

Authors:  I Royston; M B Omary; I S Trowbridge
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

8.  Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system.

Authors:  N C Davis; R C Newland
Journal:  Aust N Z J Surg       Date:  1983-06

9.  A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity.

Authors:  G Corte; A Moretta; M E Cosulich; D Ramarli; A Bargellesi
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

10.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man.

Authors:  J A Ledbetter; R L Evans; M Lipinski; C Cunningham-Rundles; R A Good; L A Herzenberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307
View more
  2 in total

1.  A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.

Authors:  Zuzana Tatarova; Dylan C Blumberg; James E Korkola; Laura M Heiser; John L Muschler; Pepper J Schedin; Sebastian W Ahn; Gordon B Mills; Lisa M Coussens; Oliver Jonas; Joe W Gray
Journal:  Nat Biotechnol       Date:  2022-07-04       Impact factor: 68.164

2.  T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.

Authors:  P A Lando; M Dohlsten; G Hedlund; E Akerblom; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.